Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta …
FB Rivera, GNO Lumbang, DRM Gaid… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aim The cardiovascular benefits provided by glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs)
extend beyond weight reduction and glycaemic control. One possible mechanism …
extend beyond weight reduction and glycaemic control. One possible mechanism …
Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and …
…, PL Pine, AMN Idian-Javier, GNO Lumbang… - Journal of Clinical …, 2024 - Elsevier
BACKGROUND Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been pivotal
in the management of type 2 diabetes mellitus (T2DM) and in the reduction of major adverse …
in the management of type 2 diabetes mellitus (T2DM) and in the reduction of major adverse …
Sex differences in trends and outcomes of acute myocardial infarction with mechanical complications in the United States
…, SW Cha, S Tang, GNO Lumbang… - Expert Review of …, 2024 - Taylor & Francis
Background Mechanical complications (MC) are rare but significant sequelae of acute myocardial
infarction (AMI). Current data on sex differences in AMI with MC is limited. Methods We …
infarction (AMI). Current data on sex differences in AMI with MC is limited. Methods We …
